F41.1 - Neonatal Disorders

Relevant Publications

[An impact of the COVID-19 pandemia on the onset and course of mental disorders in elderly].

Issue Release: 2023

Sensitivity and specificity of the Patient Health Questionnaire (PHQ-9, PHQ-8, PHQ-2) and General Anxiety Disorder scale (GAD-7, GAD-2) for depression and anxiety diagnosis: a cross-sectional study in a Peruvian hospital population.

Issue Release: 2023

Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - A case report.

Issue Release: 2021

Obsessive-Compulsive Symptoms in Obsessive-Compulsive Disorder and in Generalized Anxiety Disorder: Occurrence and Correlations.

Issue Release: 2020

[Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors].

Issue Release: 2019

Paradoxical physiological responses to propranolol in a Rett syndrome patient: a case report.

Issue Release: 2016

[Optimization of the treatment of anxiety disorders with selank].

Issue Release: 2015

[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].

Issue Release: 2014

Migraine: Clinical pattern and psychiatric comorbidity.

Issue Release: 2012

Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder.

Issue Release: 2009

Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depression.

Issue Release: 2003

Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.

Issue Release: 2003

[Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study].

Issue Release: 2000

[Cognitive processes in patients with different structure of anxiety disorders].

Issue Release: 0000

[A comparative study of the efficacy of personality-oriented (reconstructive) and cognitive-behavioral psychotherapy in neurotic anxiety disorders with insomnia].

Issue Release: 0000

[Subjective evaluation of the effect of single test doses of phenazepam and placebo in patients with anxiety disorders: a relationship with objective pharmaco-electroencephalography characteristics].

Issue Release: 0000

[Parameters of prosaccades and antisaccades as potential markers of anxiety disorders].

Issue Release: 0000

Can the Bayley Scales Predict Long-Term Outcomes?

What Are the Common Administration Methods?

What Behavioral Strategies Can Help?

What Causes Dryness in Children?

What is hemophilia and how is it managed?

What Kind of Data is Used?

Are Root Canals Safe for Children?

What is Incomplete Absorption?

What are the long-term effects on children?

What Are the Signs of Muscle Weakness in Children?

Partnered Content Networks

Relevant Topics